HSV-2 gE Envelope Protein Antibodies

Santa Cruz Biotechnology features a diverse variety of HSV-2 gE Envelope Protein monoclonal antibodies for research focused on understanding viral infection mechanisms. HSV-2 gE Envelope Protein monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The HSV-2 gE Envelope Protein plays a vital role in the viral lifecycle, facilitating viral entry into host cells and contributing to immune evasion. Understanding the function of HSV-2 gE Envelope Protein is essential for developing targeted therapies and vaccines against HSV-2, which is a significant cause of genital herpes and can lead to severe complications in immunocompromised individuals. The study of HSV-2 gE Envelope Protein advances knowledge of viral pathogenesis and improves clinical outcomes. Researchers worldwide rely on HSV-2 gE Envelope Protein monoclonal antibodies to explore viral mechanisms and host-pathogen interactions. Secondary antibodies conjugated to horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) are available to support diverse experimental needs. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of HSV-2 infection and contribute to the development of new therapeutic strategies.